Ashish Baldi

Bathinda, PB 151001, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

A new paradigm in Parkinson's disease: kidney-origin α-synuclein pathology driven by PKC signaling and aurothioglucose.

A new paradigm in Parkinson's disease: kidney-origin α-synuclein pathology driven by PKC signaling and aurothioglucose.

Journal: Inflammopharmacology

Published: April 17, 2026

Acitretin shows promising potential in Alzheimer's disease: retinoid-driven modulation of amyloid processing, neuroinflammation, and translational prospects.

Acitretin shows promising potential in Alzheimer's disease: retinoid-driven modulation of amyloid processing, neuroinflammation, and translational prospects.

Journal: Inflammopharmacology

Published: February 22, 2026

Auranofin reimagined: an emerging therapeutic candidate for neurodegenerative diseases through molecular mechanistic insights.

Auranofin reimagined: an emerging therapeutic candidate for neurodegenerative diseases through molecular mechanistic insights.

Journal: Inflammopharmacology

Published: November 18, 2025

Sovateltide at the heart-brain axis crosstalk in Alzheimer's disease: a promising multi-target and cutting-edge therapeutic approach.

Sovateltide at the heart-brain axis crosstalk in Alzheimer's disease: a promising multi-target and cutting-edge therapeutic approach.

Journal: Inflammopharmacology

Published: November 04, 2025

Targeting protein kinase C signaling cascades in alzheimer's disease: emerging neuroprotective roles of aurothioglucose.

Targeting protein kinase C signaling cascades in alzheimer's disease: emerging neuroprotective roles of aurothioglucose.

Journal: Inflammopharmacology

Published: September 07, 2025

Asperuloside: an emerging therapeutic candidate for Parkinson's disease through molecular mechanistic insights.

Asperuloside: an emerging therapeutic candidate for Parkinson's disease through molecular mechanistic insights.

Journal: Inflammopharmacology

Published: August 13, 2025

Saroglitazar at the Crossroads of Metabolic and Neurodegenerative Disease: A Critical Review of the Hepato-Neuro Axis and Translational Horizons.

Saroglitazar at the Crossroads of Metabolic and Neurodegenerative Disease: A Critical Review of the Hepato-Neuro Axis and Translational Horizons.

Journal: Neurochemical research

Published: July 03, 2025

Asperuloside as a promising multi-target agent for Alzheimer's disease: molecular mechanisms and therapeutic perspectives.

Asperuloside as a promising multi-target agent for Alzheimer's disease: molecular mechanisms and therapeutic perspectives.

Journal: Inflammopharmacology

Published: June 30, 2025

Bridging the gap: a paradigm shift in medical device regulations in India.

Bridging the gap: a paradigm shift in medical device regulations in India.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: March 15, 2025

Anandamide as a Therapeutic Target for Alleviating Neuropathic Pain and Inflammation in Rat Models.

Anandamide as a Therapeutic Target for Alleviating Neuropathic Pain and Inflammation in Rat Models.

Journal: Current neurovascular research

Published: February 07, 2025

Advancing herbal medicine safety: the need for a global pharmacovigilance approach.

Advancing herbal medicine safety: the need for a global pharmacovigilance approach.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: December 25, 2024

Harnessing network pharmacology in drug discovery: an integrated approach.

Harnessing network pharmacology in drug discovery: an integrated approach.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: October 22, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026